Collegium Pharmaceutical
Commercializes ADHD and pain-management medicines across a U.S. prescription portfolio.
$25.35
After-hours close0.00 (0.00%)
At close$25.35(−4.12%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 126.85%Insiders 3.53%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 32.43M · Float 32.05M · 98.8% free float
Institutions13F, as of Jun 30, 2026
282 holders · 41.14M shares · 46 new positions · 165 increased · 85 reduced · 34 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.44M | 16.78% | +307.2K | Aug 7, 2026 |
| Jupiter Topco LLC | 2.15M | 6.62% | +2.15Mnew | Aug 14, 2026 |
| Invesco Ltd. | 1.88M | 5.80% | +290.6K | Aug 14, 2026 |
| Fuller & Thaler Asset Management, Inc. | 1.63M | 5.03% | +133.2K | Aug 12, 2026 |
| Principal Financial Group Inc | 1.63M | 5.03% | +337.3K | Aug 4, 2026 |
| State Street Corp | 1.53M | 4.71% | +104.3K | Aug 7, 2026 |
| Massachusetts Financial Services Co /MA/ | 1.41M | 4.33% | +39.6K | Aug 3, 2026 |
| Vanguard Capital Management LLC | 1.38M | 4.26% | +47.3K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.60% | 5.00M | 13G | Apr 28, 2025 ↗ |
| Janus Henderson Group PLC | 5.80% | 1.83M | 13G | May 15, 2026 ↗ |
| Principal Global Investors, LLC | 5.42% | 1.75M | Nov 13, 2024 ↗ | |
| Integrated Core Strategies (US) LLC | 5.40% | 1.77M | 13G | Aug 24, 2026 ↗ |
| Fuller & Thaler Asset Management, Inc. | 5.03% | 1.63M | 13G | Aug 14, 2026 ↗ |
| Vanguard Capital Management | 5.01% | 1.63M | 13G | Jul 31, 2026 ↗ |
| Principal Global Investors | 5.00% | 1.63M | 13G | Aug 5, 2026 ↗ |
| Invesco Ltd. | 5.00% | 1.59M | 13G | May 8, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Rubric Capital Management LP | 10 percent owner | 3.13M | 9.66% | Aug 15, 2025 |
| Vikram Karnani | director, officer: President and CEO | 176.6K | 0.54% | Feb 12, 2026 |
| Colleen Tupper | officer: EVP & Chief Financial Officer | 147.3K | 0.45% | Feb 12, 2026 |
| Gino Santini | director | 112.5K | 0.35% | Jun 10, 2026 |
| Shirley R. Kuhlmann | officer: EVP and General Counsel | 108.1K | 0.33% | Mar 6, 2025 |
| John Gordon Freund | director | 107.1K | 0.33% | May 20, 2026 |
| Thomas B. Smith | officer: EVP and Chief Medical Officer | 85.3K | 0.26% | Feb 12, 2026 |
| Scott Dreyer | officer: EVP & Chief Commercial Officer | 71.8K | 0.22% | Mar 5, 2026 |
| Garen G. Bohlin | director | 71.0K | 0.22% | May 18, 2026 |
| David Dieter | officer: EVP & General Counsel | 68.2K | 0.21% | Apr 3, 2026 |
7 ten-percent owners hold 7.85M shares by Form 4, outside the officers-and-directors figure above · 12 people have not refiled in the last 18 months (1.73M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 18, 2026 | John Gordon Freunddirector | Sale | 20 | $34.05 | 83,952 |
| May 15, 2026 | John Gordon Freunddirector | Sale | 4,127 | $34.54 | 83,972 |
| May 13, 2026 | Nancy Lurkerdirector | Sale | 4,500 | $35.97 | 18,017 |
| May 11, 2026 | Garen G. Bohlindirector | Sale | 8,700 | $37.18 | 62,259 |
| Mar 18, 2026 | David Dieterofficer: EVP & General Counsel | Sale | 13,976 | $34.92 | 77,071 |
| Mar 9, 2026 | David Dieterofficer: EVP & General Counsel | Sale | 6,224 | $36.65 | 91,047 |
| Mar 3, 2026 | Scott Dreyerofficer: EVP & Chief Commercial Officer | Sale · 2 lots | 49,976 | $40.41 | 71,770 |
| Dec 8, 2025 | Scott Dreyerofficer: EVP & Chief Commercial Officer | Sale · 2 lots | 17,600 | $48.17 | 103,613 |
| Dec 5, 2025 | Rita J. Balice-Gordondirector | Sale | 3,650 | $47.03 | 52,629 |
| Nov 12, 2025 | John A. Fallondirector | Sale | 34,853 | $47.21 | 64,634 |
CongressHouse and Senate disclosures
Not reported.